Say Hello!
Don’t be shy.


Phenotypeca Tag

Next-generation yeast strain developer and BioCity client company, Phenotypeca Ltd, has been awarded funding from the Future Vaccine Manufacturing Research Hub (Vax-Hub) to conduct a feasibility study that will exploit the genetic diversity of baker’s yeast to optimise virus-like particles (VLPs) for vaccine production. Vax-Hub launched...